Evidence map›Paper›PMID 37093397›Full record

ArticleCell biology and toxicology2023

GABA

Konstantina Bampali, Filip Koniuszewski, Florian D Vogel, Jure Fabjan, Christos Andronis, Eftychia Lekka, Vassilis Virvillis, Thomas Seidel, Annie Delaunois, Leandro Royer and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Cell biology and toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Konstantina BampaliDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Spitalgasse 4, 1090, Vienna, Austria.
Filip KoniuszewskiDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Spitalgasse 4, 1090, Vienna, Austria.
Florian D VogelDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Spitalgasse 4, 1090, Vienna, Austria.
Jure FabjanDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Spitalgasse 4, 1090, Vienna, Austria.
Christos AndronisBiovista, 34 Rodopoleos Street, 16777, Athens, Greece.
Eftychia LekkaBiovista, 34 Rodopoleos Street, 16777, Athens, Greece.
Vassilis VirvillisBiovista, 34 Rodopoleos Street, 16777, Athens, Greece.
Thomas SeidelDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria.
Annie DelaunoisUCB Biopharma SRL, Chemin du Foriest, Braine-L'Alleud, Belgium.
Leandro RoyerUCB Biopharma SRL, Chemin du Foriest, Braine-L'Alleud, Belgium.
Michael G RolfR&D Biopharmaceuticals, Astra Zeneca, Pepparedsleden 1, 431 83, Mölndal, Sweden.
Chiara GiulianoR&D Biopharmaceuticals, Astra Zeneca, Fleming Building (B623), Babraham Research Park, Babraham, Cambridgeshire, CB22 3AT, UK.
Martin TraebertNovartis Institutes for Biomedical Research, Fabrikstrasse 2, CH-4056, Basel, Switzerland.
Gautier RoussignolSanofi R & D, Preclinical Safety, Montpellier, France.
Magali Fric-BordatSanofi R & D, Preclinical Safety, Montpellier, France.
Ludmilla Mazelin-WinumSanofi R & D, Preclinical Safety, Montpellier, France.
Sharon D BryantInte:Ligand GmbH, Mariahilferstrasse 74B/11, 1070, Vienna, Austria.
Thierry LangerDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090, Vienna, Austria.
Margot ErnstDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Spitalgasse 4, 1090, Vienna, Austria. margot.ernst@meduniwien.ac.at.
Medical University of Vienna · ATSanofi (France) · FRUCB Pharma (Belgium) · BEUniversity of Vienna · ATAstraZeneca (Sweden) · SEAstraZeneca (United Kingdom) · GBInte:Ligand (Austria) · ATNovartis (Switzerland) · CH

Funding

Austrian Science Fund FWF DOC 33Austrian Science Fund FWF W 1232
6 · The paper itself

Abstract

GABA

Indexed as

Receptors, GABA-AZebrafishAnimalsBinding Sitesgamma-Aminobutyric AcidSeizuresgamma-Aminobutyric AcidReceptors, GABA-AAllosteric sitesAmoxapineGABAA receptorPharmacotoxicologySeizures

Identifiers

PMID37093397
PMCPMC10693519
OpenAlexW4366819391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.